Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.
第一作者:
Meredith,Castro
第一单位:
Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. mcastr80@its.jnj.com.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);人类(Humans);中年人(Middle Aged);青年人(Young Adult);抗抑郁药(Antidepressive Agents);临床试验(主题)(Clinical Trials as Topic);氯胺酮(Ketamine);鼻用喷雾剂(Nasal Sprays);治疗结果(Treatment Outcome)
DOI
10.1007/s40263-023-01026-3
PMID
37558912
发布时间
2024-03-12
- 浏览1
CNS drugs
715-723页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



